Kimberly Claeys, PharmD, PhD, an infectious disease pharmacist, will lead a multidisciplinary team focused on incorporating the 4Ms of age-friendly care to improve clinician workflow and patient outcomes in older adults with suspected UTI.

James Polli and Lisa Lebovitz received honors at the AACP Annual Meeting in July.

The advisory board received UMB’s Catalyst of Excellence Award.

Diverse cohort of scholars represent seven graduate programs.

Dr. Randal D. Pinkett is an entrepreneur, author, and diversity, equity, and inclusion expert.

The School of Pharmacy’s newest dean is ready to take the School into the future.

M-CERSI is a collaboration between the University of Maryland School of Pharmacy and the University of Maryland, College Park.

Early oncology clinical development positions available exclusively to School’s PharmD graduates.

Maryland Governor Wes Moore has appointed Leah Sera, Chad Johnson, and Zafar Zafari to multiyear terms.

Research from the lab of Jana Shen looks at a mutation causing diminished effectiveness of Paxlovid.

James Polli, PhD, leads multiple intercampus research centers in regulatory science and drug quality.

Ester Villalonga Olives is an associate professor of practice, sciences, and health outcomes research.